FDA Import Refusal SCS-0405203-5/11/2 — Medley Pharmaceuticals
The FDA refused shipment SCS-0405203-5/11/2 from Medley Pharmaceuticals (India) on Oct 3, 2023. The refused product falls under Drugs and Biologics — OLMESARTAN MEDOXOMIL. Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 3, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62CDB68 OLMESARTAN MEDOXOMIL
- Charges
- 118,75